ORIGINAL RESEARCH article

Front. Oncol.

Sec. Thoracic Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1489327

This article is part of the Research TopicRecent Advancements and Developments in Targeted Drug Delivery Systems for Cancer Diagnosis and TherapyView all 6 articles

Second-Line Chemotherapy Rechallenge in Lung Cancer Patients: A Moroccan Real-World Study

Provisionally accepted
Hassan Abdelilah  TafenziHassan Abdelilah Tafenzi1,2*Farah  ChoulliFarah Choulli1,2Ismail  EssaadiIsmail Essaadi1,3Rhizlane  BelbarakaRhizlane Belbaraka1,2
  • 1Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
  • 2Department of Medical Oncology, Mohammed VI University Hospital of Marrakech., Marrakech, Morocco
  • 3Medical Oncology Department, Avicenna Military Hospital of Marrakech, Marrakech, Morocco

The final, formatted version of the article will be published soon.

please see the Abstract section in the main manuscript

Keywords: lung cancer, Real world data (RWD), Chemotherapy rechallenge, Moroccan cohort, Second-line

Received: 31 Aug 2024; Accepted: 28 Apr 2025.

Copyright: © 2025 Tafenzi, Choulli, Essaadi and Belbaraka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hassan Abdelilah Tafenzi, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.